American depository receipts of European stocks were trading slightly higher at 123.23 on the Bank of New York Mellon Europe ADR Index on Friday.
In continental Europe, the gainers were led by biotech firm Zealand Pharma ( ZEAL ) and software company Talend ( TLND ), which climbed 6.4% and 5.6% respectively. They were followed by pharmaceutical company Oasmia Pharmaceutical ( OASM ) and oil and gas company Eni ( E ), which rose 3.9% and 3.4%.
The decliners in continental Europe were led by kidney dialysis company Fresenius Medical Care ( FMS ), which fell 9.3%, followed by internet browser company Opera (OPRA), biotech firm ERYTECH Pharma (ERYP), and medical equipment company Edap (EDAP), which lost 2.2%, 1.8%, and 1.5% respectively.
In the UK and Ireland, the gainers were led by biopharmaceutical firm GW Pharmaceuticals (GWPH) and medical equipment maker Smith & Nephew (SNN), which rose 2.6% and 2.4% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX), and construction materials supplier CRH (CRH), which were up 2% and 1.5%.
The decliners in the UK and Ireland were led in part by airline operator Ryanair (RYAAY), biotech firm Shire (SHPG), and gene therapy company Nightstar (NITE), which were off 2.8%, 2.7%, and 2.1% respectively.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
Zeen is a next generation WordPress theme. It’s powerful, beautifully designed and comes with everything you need to engage your visitors and increase conversions.
Go to Appearance > Customize > Subscribe Pop-up to set this up.
Wealth Empire Newsletter
Register now for free updates and alerts
Note: I have the ability to revoke this permission at any time and ask for the removal of my personal data collected by contacting us or simply clicking Unsubscribe.